PALO ALTO, Calif., June 3, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) and other serious diseases, today announced that...
News Ticker
- [ June 8, 2023 ] Lab Technician II, Lab Ops – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ June 8, 2023 ] Research Associate, Scientist, or Senior Scientist – CHO Plus – San Francisco, CA San Francisco Biotech Jobs
- [ June 8, 2023 ] Scientist, Senior Scientist, or Director – CHO Plus – San Francisco, CA San Francisco Biotech Jobs
- [ June 8, 2023 ] Scientist II (AKTA chromatographic, HPLC, ELISA, purification, analytical) – Tellus Solutions – South San Francisco, CA San Francisco Biotech Jobs
- [ June 8, 2023 ] Protein Science Associate – Nura Bio – South San Francisco, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
